Product Images Butrans
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 31 images provide visual information about the product associated with Butrans NDC 59011-750 by Purdue Pharma Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
302919 0C 5 mcg pouch
302920 0C 10 mcg pouch
302921 0C 20 mcg pouch
This appears to be a product description for "Butrans Transdermal System," a medication containing buprenorphine used for the treatment of pain. The pack contains 5 patches, and each patch contains 20g of the active ingredient. The medication is administered through a transdermal system which is to be applied every 8 to 16 hours, and caution should be taken to keep the product out of reach of children. The text includes some potentially misspelled words due to errors.*
302922 0D 5 mcg carton
302923 0D 10 mcg carton
302924 0D 20 mcg carton
30300 0C 15 mcg pouch
303301 0D 15 mcg carton
303368 0B 7.5 mcg pouch
303369 0C 7.5 mcg carton
Figure A Instructions - butrans instr figa
Figure B Instructions - butrans instr figb
Figure C Instructions - butrans instr figc
Figure D Instructions - butrans instr figd
Figure E Instructions - butrans instr fige
Figure F Instructions - butrans instr figf
Figure G Instructions - butrans instr figg
Figure H Instructions - butrans instr figh
Figure I Instructions - butrans instr figi
Figure J Instructions - butrans instr figj
Figure K Instructions - butrans instr figk
Figure L Instructions - butrans instr figl
Figure M Instructions - butrans instr figm
Figure N Instructions - butrans instr fign
Figure O Instructions - butrans instr figo
butrans-structure - butrans structure
figure-1 - figure 1
This appears to be a description of a layered product used for drug delivery. The product consists of five layers - the backing layer, overlapping adhesive film, separating layer, drug/polymer adhesive matrix, and a peel-off release liner. The specific purpose and application of this product is not clear from the given text.*
figure-2 - figure 2
This is a chart displaying the concentration (in pg/mL) of o-Butrans over time (in days) for a group of 36 individuals who received a 10mg/hour dosage once every 7 days for 3 weeks. It also shows the removal of Butrans over time.*
figure-3 - figure 3
This is a graph representing the percentage of patients improved in a medical trial. The X-axis represents the percentage of reduction/improvement in pain, ranging from 0% to 280%. The Y-axis represents the percentage of patients improved, ranging from 0% to 100%. The trial compares a placebo group with a drug called Bulrans 10720. It appears that the drug had a higher percentage of patients improved compared to the placebo, as shown by the graph.*
figure-4 - figure 4
This seems to be a chart or a graph showing the percentage of patients who improved their pain after using a medication called "Butrans20". The chart goes from 0% to 100% in increments of 10%. However, there is no clear indication of what axis the improvement percentages are listed on.*
table-1 - table 1
This appears to be part of a medical chart or prescription record. It mentions a previous opioid analgesic and the daily dose in terms of morphine equivalent. It also recommends a medication called Butrans and mentions a starting dose. Without additional context, it is difficult to provide a more specific description.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.